![](https://cme.healthonecares.com/sites/default/files/styles/course_image/public/course/2022-08/Neurons%20Epilepsy%20120x68.jpg?itok=4mkD_fJe)
Identify and Manage Epilepsy in Primary Care
This course will introduce healthcare professionals and patients to a wide spectrum of new and established therapies for adults and children with epilepsy. Individualized approaches to treat epilepsy, including tailored drug and surgical therapies will be discussed. This course will provide insight and strategy to enhance the quality of life and cognitive function for people with epilepsy.
Target Audience
This educational activity is intended for practicing adult and pediatric neurologists and epileptologists, Neurology and Neurosurgery residents and fellowship trainees, as well as mid-level providers, nursing, Physician Assistants and other health care personnel engaged in epilepsy care.
Learning Objectives
- Discuss state-of-the-art diagnostic and therapeutic developments in the management of epilepsy
- Describe the pharmacology and action of anti seizure medications (ASMs)
- Review unique epilepsies including rare syndromes, diseases, neuro-cutaneous disorders, and autoimmune epilepsies
- Discuss treating acute repetitive seizures and status epilepticus
- Review epilepsy surgery updates and techniques including neuromodulation and ablative procedures
Oliver Jeffery, MBChB
Disclosure: There are no relevant financial relationships to report for those individuals in a position to control the content of this CME Activity
Accreditation: The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation: The HCA Healthcare Continental Division designates this enduring activity for a maximum of 1.0 AMA PRA Category 1TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support: This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.
Disclosure: The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.
Available Credit
- 1.00 AMA PRA Category 1 Credit™HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
HCA Healthcare Continental Division designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 1.00 Attendance
- Register for the activity and create a profile including login/password.
- Review the required accreditation information: Target audience, learning objectives, and disclosure information.
- Complete the entire activity.
- Complete the post-test assessments.
- Successfully pass the post-test with a minimum score of 70%.
- Complete the evaluation survey.
- Obtain a certificate.